LTR Pharma Limited
LTPLF
$0.27
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -100.33% | -181.89% | -365.76% | -- | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 77.85% | 279.02% | 2,815.49% | -- | -- |
| Change in Net Operating Assets | 529.50% | 529.50% | 529.50% | -- | -- |
| Cash from Operations | -77.73% | -129.09% | -223.17% | -- | -- |
| Capital Expenditure | -407.14% | -207.14% | 0.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -407.14% | -207.14% | 0.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 320.24% | 329.50% | 383.56% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -271.73% | -310.28% | -630.43% | -- | -- |
| Cash from Financing | 326.11% | 334.75% | 355.58% | -- | -- |
| Foreign Exchange rate Adjustments | -15.00% | -15.00% | -15.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 479.79% | 536.56% | 837.34% | -- | -- |